103 related articles for article (PubMed ID: 2990656)
1. Serum copper level in ovarian carcinoma.
Margalioth EJ; Udassin R; Maor J; Schenker JG
Cancer; 1985 Aug; 56(4):856-9. PubMed ID: 2990656
[TBL] [Abstract][Full Text] [Related]
2. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
Mathew GK; Singh SS; Swaminathan RG; Tenali SG
J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
[TBL] [Abstract][Full Text] [Related]
3. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
Zhang M; Jiang W; Li G; Xu C
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
[TBL] [Abstract][Full Text] [Related]
4. [The copper concentration in the blood serum of women with ovarian tumors (a preliminary report)].
Marinov B; Tsachev K; Doganov N; Dzherov L; Atanasova B; Markova M
Akush Ginekol (Sofiia); 2000; 39(2):36-7. PubMed ID: 10948620
[TBL] [Abstract][Full Text] [Related]
5. Serum copper in ovarian carcinoma.
Jacobs AJ; Sommers GM; Axelrod JH; Galakatos AE; Kao MS; Camel HM
Cancer; 1988 Mar; 61(5):1015-7. PubMed ID: 3422179
[TBL] [Abstract][Full Text] [Related]
6. Prediction of the presence of ovarian cancer at surgery by an immunochemical panel: CA 125 and copper-to-zinc ratio.
Gal D; Lischinsky S; Friedman M; Zinder O
Gynecol Oncol; 1989 Nov; 35(2):246-50. PubMed ID: 2680799
[TBL] [Abstract][Full Text] [Related]
7. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
[TBL] [Abstract][Full Text] [Related]
8. Second-look operations in ovarian cancer.
Schwartz PE; Smith JP
Am J Obstet Gynecol; 1980 Dec; 138(8):1124-30. PubMed ID: 7446620
[TBL] [Abstract][Full Text] [Related]
9. Serum copper levels in carcinoma of ovary and cervix.
Saxena P; Yadav S; Salhan S; Bhowmick KT
Indian J Physiol Pharmacol; 2002 Apr; 46(2):159-66. PubMed ID: 12500490
[TBL] [Abstract][Full Text] [Related]
10. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients.
Bozkurt N; Yuce K; Basaran M; Gariboglu S; Kose F; Ayhan A
Int J Gynecol Cancer; 2006; 16(1):83-6. PubMed ID: 16445615
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment of ovarian tumors, especially ovarian carcinomas].
Käser O
Fortschr Med; 1975 Oct; 93(28):1317-22. PubMed ID: 179919
[TBL] [Abstract][Full Text] [Related]
13. Combined drug therapy for ovarian carcinoma.
Li MC; Hsu KP
Clin Obstet Gynecol; 1970 Dec; 13(4):928-44. PubMed ID: 4325125
[No Abstract] [Full Text] [Related]
14. Ovarian carcinoma; second-look laparotomy postchemotherapy. Preliminary report.
Webster KD; Ballard LA
Cleve Clin Q; 1981; 48(4):365-71. PubMed ID: 6276049
[No Abstract] [Full Text] [Related]
15. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
Ballas M
Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy of cancer of the ovary].
Cappelaere P; Horner-Vallet D; Demaille A
Bull Cancer; 1984; 71(4):363-9. PubMed ID: 6498348
[TBL] [Abstract][Full Text] [Related]
17. [Extensive and radical surgery for primary ovarian cancer].
Chen DX
Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):165-6, 190. PubMed ID: 1327671
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers in germ cell tumors. Clinical use and research aspects].
Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
[No Abstract] [Full Text] [Related]
20. Postoperative changes in serum copper value.
Gregoriadis GC; Apostolidis NS; Romanos AN; Paradellis TP
Surg Gynecol Obstet; 1982 Feb; 154(2):217-21. PubMed ID: 7058481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
